For adults with T2DM, statin initiation is associated with reductions in all-cause mortality and major CVD risk.

Circadian rhythms that are weaker and more fragmented were found to be associated with an increased risk for dementia.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

The U.S. Centers for Disease Control and Prevention has reduced the number of diseases protected by routine childhood vaccines from 17 to 11. HealthDay News — Federal health officials have decided to ...

Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.

Management of mitochondrial-related heart disease relies on multidisciplinary care and symptom control, as targeted gene-editing therapies are limited.

For Black breast cancer survivors, higher consumption of ultra-processed foods (UPFs) seems to adversely affect breast cancer prognosis.

The FDA has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).

The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

For patients at high cardiovascular risk with overweight/obesity, semaglutide is associated with reduced burden of total hospital admissions.

Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.

Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.